These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 16116698)

  • 1. Meta-analysis of the relationship of Factor V Leiden and intrauterine growth restriction--based on solid evidence?
    Lindqvist PG; Merlo J
    Thromb Haemost; 2005 Jul; 94(1):230-1; author reply 231-2. PubMed ID: 16116698
    [No Abstract]   [Full Text] [Related]  

  • 2. The association between adverse pregnancy outcomes and maternal factor V Leiden genotype: a meta-analysis.
    Dudding TE; Attia J
    Thromb Haemost; 2004 Apr; 91(4):700-11. PubMed ID: 15045131
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mannose-binding lectin (MBL) codon 54 gene polymorphism protects against development of pre-eclampsia, HELLP syndrome and pre-eclampsia-associated intrauterine growth restriction.
    Sziller I; Babula O; Hupuczi P; Nagy B; Rigó B; Szabó G; Papp Z; Linhares IM; Witkin SS
    Mol Hum Reprod; 2007 Apr; 13(4):281-5. PubMed ID: 17314117
    [TBL] [Abstract][Full Text] [Related]  

  • 4. STOX1 gene in pre-eclampsia and intrauterine growth restriction.
    Berends AL; Bertoli-Avella AM; de Groot CJ; van Duijn CM; Oostra BA; Steegers EA
    BJOG; 2007 Sep; 114(9):1163-7. PubMed ID: 17617193
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Factor V Leiden is associated with pre-eclampsia but not with fetal growth restriction: a genetic association study and meta-analysis.
    Dudding T; Heron J; Thakkinstian A; Nurk E; Golding J; Pembrey M; Ring SM; Attia J; Scott RJ
    J Thromb Haemost; 2008 Nov; 6(11):1869-75. PubMed ID: 18752569
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Addendum to: The association between adverse pregnancy outcomes and maternal factor V Leiden genotype. A meta-analysis.
    Attia J; Dudding T; Infante-Rivard C
    Thromb Haemost; 2004 Aug; 92(2):434. PubMed ID: 15269846
    [No Abstract]   [Full Text] [Related]  

  • 7. The impact of the factor V Leiden mutation on pregnancy.
    Spina V; Aleandri V; Morini F
    Hum Reprod Update; 2000; 6(3):301-6. PubMed ID: 10874575
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Impact of inherited thrombophilia on the development of some pregnancy complications].
    Koleva R; Dimitrova V; Chernev T; Savov A; Karag'ozova Zh; Mazneŭkova V; Kremenski I
    Akush Ginekol (Sofiia); 2005; 44(5):18-26. PubMed ID: 16313049
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Factor V Leiden in pregnancies complicated by placental abruption.
    Facchinetti F
    BJOG; 2004 Jan; 111(1):93; author reply 93-4. PubMed ID: 14687065
    [No Abstract]   [Full Text] [Related]  

  • 10. [Pregnancy outcomes in a patient-heterozygous carrier of R506Q mutation of factor V (Leiden)].
    Herman M; Djelmis J; Troselj Z; Ivanisević M
    Acta Med Croatica; 2006 Jun; 60(3):277-80. PubMed ID: 16933843
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A systematic review of the association between factor V Leiden or prothrombin gene variant and intrauterine growth restriction.
    Howley HE; Walker M; Rodger MA
    Am J Obstet Gynecol; 2005 Mar; 192(3):694-708. PubMed ID: 15746660
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thrombophilic mutations in pre-eclampsia and pregnancy-induced hypertension.
    Omar SZ; Qvist R; Khaing SL; Muniandy S; Bhalla S
    J Obstet Gynaecol Res; 2008 Apr; 34(2):174-8. PubMed ID: 18412778
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thrombophilias and adverse pregnancy outcome - A confounded problem!
    Kist WJ; Janssen NG; Kalk JJ; Hague WM; Dekker GA; de Vries JI
    Thromb Haemost; 2008 Jan; 99(1):77-85. PubMed ID: 18217138
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Familial aggregation of preeclampsia and intrauterine growth restriction in a genetically isolated population in The Netherlands.
    Berends AL; Steegers EA; Isaacs A; Aulchenko YS; Liu F; de Groot CJ; Oostra BA; van Duijn CM
    Eur J Hum Genet; 2008 Dec; 16(12):1437-42. PubMed ID: 18612323
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of extracellular superoxide dismutase (SOD3) Ala40Thr gene polymorphism with pre-eclampsia complicated by severe fetal growth restriction.
    Rosta K; Molvarec A; Enzsöly A; Nagy B; Rónai Z; Fekete A; Sasvári-Székely M; Rigó J; Vér A
    Eur J Obstet Gynecol Reprod Biol; 2009 Feb; 142(2):134-8. PubMed ID: 19108943
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Factor V Leiden, pregnancy complications and adverse outcomes: the Hordaland Homocysteine Study.
    Nurk E; Tell GS; Refsum H; Ueland PM; Vollset SE
    QJM; 2006 May; 99(5):289-98. PubMed ID: 16613994
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association between tumor necrosis factor (TNF)-alpha G-308A gene polymorphism and preeclampsia complicated by severe fetal growth restriction.
    Molvarec A; Jermendy A; Nagy B; Kovács M; Várkonyi T; Hupuczi P; Prohászka Z; Rigó J
    Clin Chim Acta; 2008 Jun; 392(1-2):52-7. PubMed ID: 18396154
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Parent-of-origin transmission of thrombophilic alleles to intrauterine growth-restricted newborns and transmission-ratio distortion in unaffected newborns.
    Infante-Rivard C; Weinberg CR
    Am J Epidemiol; 2005 Nov; 162(9):891-7. PubMed ID: 16192348
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship between polymorphisms in thrombophilic genes and preeclampsia in a Brazilian population.
    Dalmáz CA; Santos KG; Botton MR; Tedoldi CL; Roisenberg I
    Blood Cells Mol Dis; 2006; 37(2):107-10. PubMed ID: 16963292
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improved hemoglobin status and reduced menstrual blood loss among female carriers of factor V Leiden--an evolutionary advantage?
    Lindqvist PG; Zöller B; Dahlbäck B
    Thromb Haemost; 2001 Oct; 86(4):1122-3. PubMed ID: 11686338
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.